Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

NCR graphs - Age specific incidence rates

- All cancer age-specific incidence rates, including non-melanoma skin cancer, males, Lebanon, 2009, 2014, 2019, 2024
- All cancer age-specific incidence rates, including non-melanoma skin cancer, females, Lebanon, 2009, 2014, 2019, 2024

- All cancer age-specific incidence rates, excluding non-melanoma skin cancer, males, Lebanon, 2009, 2014, 2019, 2024
- All cancer age-specific incidence rates, excluding non-melanoma skin cancer, females, Lebanon, 2009, 2014, 2019, 2024

- Oesophagus cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Oesophagus cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Estomac cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Estomac cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Colo-rectal cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Colo-rectal cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Liver cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Liver cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Pancreas cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Pancreas cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Larynx cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Larynx cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Trachea-bronchus-lung cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Trachea-bronchus-lung cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Melanoma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Melanoma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Non-melanoma skin cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Non-melanoma skin cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Breast cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Breast cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Col uteri cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024
- Corpus uteri cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024
- Ovary cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Prostate cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024

- Kidney cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Kidney cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Bladder cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Bladder cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Brain and central nervous system cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Brain and central nervous system cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Thyroid cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Thyroid cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Hodgkin's lymphoma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Hodgkin's lymphoma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Non-Hodgkin lymphoma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Non-Hodgkin lymphoma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Multiple Myeloma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Multiple Myeloma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Lymphoid leukemia age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Lymphoid leukemia age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Myeloid leukemia age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Myeloid leukemia age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024
 
    4
    ...
ATC Name B/G Ingredients Dosage Form Price
B05BB02 DEXTROSE 5% IN LACTATED RINGER'S G Sodium lactate - 0.31g/100ml, Calcium chloride 2H2O - 0.02g/100ml, Potassium chloride - 0.03g/100ml, Sodium chloride - 0.598g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 207,404 L.L
D06BA51 HYALO4 PLUS G Hyaluronic acid (sodium) - 0.2%, Silver sulfadiazine - 1% Cream 466,313 L.L
R03AL06 SPIOLTO RESPIMAT B Olodaterol HCl - 2.5mcg/puff, Tiotropium bromide monohydrate - 2.5mcg/puff Inhalation solution 5,087,788 L.L
A06AD65 MOVICOL PEDIATRIC PLAIN B Potassium chloride - 23.3mg, Sodium chloride - 175.4mg, Sodium bicarbonate - 89.3mg, Macrogol 3350 - 6.563g Powder for solution 624,887 L.L
B05BB02 DEXTROSE 5% & SODIUM CHLORIDE 0.2% G Sodium chloride - 0.2g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 194,165 L.L
D06BA51 IALUGEN PLUS B Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 0.5mg/g Gauze 1,463,444 L.L
R03AL11 BREZTRI AEROSPHERE B Formoterol fumarate dihydrate - 5mcg, Glycopyrronium Bromide - 7.2mcg, Budesonide - 160mcg Inhalation suspension 6,705,774 L.L
A06AG11 MINILAX G Sodium citrate (dihydrate) - 900mg/10ml, Sodium lauryl sulfate - 150mg/10ml, Glycerol - 1200mg/10ml, Sorbic acid - 10mg/10ml, Sorbitol - 9.96mg/10ml Solution 474,824 L.L
B05BB02 DEXTROSE 5% & SODIUM CHLORIDE 0.2% G Sodium chloride - 0.2g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 220,643 L.L
D06BA51 SILVEZ PLUS G Silver sulfadiazine - , Chlorhexidine - Cream 349,399 L.L
G03FB01 PROGYLUTON B Norgestrel - 0.5mg (tablet 2), Estradiol valerate - 2mg (tablet 1, tablet 2) Tablet 193,513 L.L
A06AX01 SUPPOSITOIRE GLYCERINE ENFANT G Glycerol Stearate USP - Suppository 179,179 L.L
A10BD20 EMPAZIMET G Metformin HCl - 1000mg, Empagliflozin - 5mg Tablet, film coated 1,840,168 L.L
B05BB02 DEXTROSE 5% & SODIUM CHLORIDE 0.3% G Sodium chloride - 0.3g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 188,772 L.L
M02AX10 ALGESAL SURACTIVE B Salycilic acid - 6.54g/100g, Diethylamine - 3.46g/100g, Myrtecaine - 1g/100g Cream 1,006,538 L.L
A06AX01 SUPPOSITOIRE GLYCERINE ENFANT G Glycerol Stearate USP - Suppository 179,179 L.L
A10BD20 FLORIMET 5/1000 G Metformin - 1000mg, Empagliflozin - 5mg Tablet, film coated 1,836,585 L.L
B05BB02 DEXTROSE 5% & SODIUM CHLORIDE 0.3% G Sodium chloride - 0.3g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 204,554 L.L
A06AX01 SUPPOSITOIRE GLYCERINE ADULTE G Glycerol Stearate USP - Suppository 179,179 L.L
A10BD21 ENFORZA B Saxagliptin HCl - 5mg, Dapagliflozin - 10mg Tablet, film coated 6,072,824 L.L
B05BB02 DEXTROSE 5% & SODIUM CHLORIDE 0.3% G Sodium chloride - 0.3g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 220,643 L.L
D06BB53 ACTI-VIR H G Aciclovir - 5%, Hydrocortisone acetate - 1% Cream 833,182 L.L
B02BD06 HAEMATE P BioHuman Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU Injectable lyophilised powder for solution+diluent L.L
L01FY02 OPDUALAG BioTech Nivolumab - 240mg/20ml, Relatlimab - 80mg/20ml Injectable solution 764,283,658 L.L
N02BE51 ADOL EXTRA G Paracetamol - 500mg, Caffeine - 65mg Caplet 122,290 L.L
N02BE51 SICADOL EXTRA G Paracetamol - 500mg, Caffeine - 65mg Tablet 147,823 L.L
L04AE04 PONVORY B Ponesimod - 2x2mg, 2x3mg, 2x4mg, 1x5mg, 1x6mg, 1x7mg, 1x8mg, 1x9mg, 3x10mg Tablet, film coated 37,059,944 L.L
N02BE51 A.B.C NIGHT G Paracetamol - 500mg, Diphenhydramine HCl - 25mg Tablet, film coated 222,694 L.L
J01DH51 CELLABAXIN G Imipenem (monohydrate) - 500mg, Cilastatin (sodium) - 500mg Injectable solution 10,699,559 L.L
N02BE51 PANADOL SINUS B Paracetamol - 500mg, Pseudoephedrine HCl - 30mg Caplet 228,453 L.L
    4
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026